Glenn W. Stevenson, Ph.D.
Location
Before joining the faculty in 2005, Dr. Stevenson had two successful careers: one as a professional musician in Boston; the other working for luxury hotel brands in Washington, D.C. and Boston. Dr. Stevenson embarked on his third career by completing a Ph.D. in behavioral neuroscience at American University. Following his graduate training, he did a post-doctoral fellowship in pharmacology at McLean Hospital/Harvard Medical School.
Dr. Stevenson鈥檚 research at 51小黄车has focused on drug discovery, preclinical evaluation of experimental medications for the treatment of pain, and development of preclinical methods for evaluating pain. His lab has collaborated with researchers at Harvard, NIH, University of Arizona, U Penn, and 51小黄车COM. Dr. Stevenson closed his lab in 2024, in order to focus his scholarship efforts solely on book writing. He aims to submit his first book for publication by 2025.
Credentials
Education
Post-Doctoral Training
McLean Hospital-Harvard Medical School (2002 - 2005)
Research
Selected publications
(*Signifies current or former 51小黄车CAS undergraduate, COM, or CDM student co-author)
*Payne E, *Harrington K, *Richard P, *Brackin R, *Davis R, *Couture S, *Liff J, *Asmus F, *Mutina E, *Fisher A, Giuvelis D, Sannajust S, Rostama B, King T, Mattei LM, Lee J-J, Friedman ES, Bittinger K, May M, Stevenson GW. Effects of vancomycin on persistent pain-stimulated and pain-depressed behaviors in female fischer rats with or without voluntary access to running wheels. The Journal of Pain, 22(11): 1530-1544; 2021.
Stevenson GW, Giuvelis D, *Cormier J, *Cone K, *Atherton P, *Krivitsky R, *Warner E, *St. Laurent B, *Dutra J, Bidlack JM, Szab貌 L, Polt R, Bilsky EJ. Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration. Psychopharmacology, 237: 1195-1208; 2020.
*Cone K, *Lanpher J, *Kinens A, *Richard P, *Couture S, *Brackin R, *Payne E, *Harrington K, Rice KC, Stevenson GW. Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats. Psychopharmacology, 235(5):1609-1618; 2018.
*Cormier J, *Cone K, *Lanpher J, *Kinens A, Henderson T, Liaw L, Bilsky EJ, King T, Rosen CJ, Stevenson GW. Exercise reverses pain-related weight asymmetry and differentially modulates trabecular bone microarchitecture in a rat model of osteoarthritis. Life Sciences, 180:51-19; 2017.
*Warner E, *Krivitsky R, *Cone K, *Atherton P, *Pitre T, *Lanpher J, Giuvelis D, Bergquist I, King T, Bilsky EJ, Stevenson GW. Evaluation of a post-operative pain-like state on motivated behavior in rats: Effects of plantar incision on progressive-ratio food-maintained responding. Drug Development Research, 76(8):432-441; 2015.
Stevenson GW, *Luginbuhl A, *Dunbar C, *LaVigne J, *Dutra J, *Atherton P, *Bell B, *Cone K, Giuvelis D, Polt R, Streicher JM, Bilsky EJ. The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence. Pharmacology, Biochemistry and Behavior, 132:49-55; 2015.
Stevenson GW, *Mercer H, *Cormier J, *Dunbar C, *Benoit L, *Adams C, *Jezierski J, *Luginbuhl A, Bilsky EJ. Monosodium iodoacetate-induced osteoarthritis pain-depressed wheel running in rats: Implications for preclinical behavioral assessment of chronic pain. Pharmacology, Biochemistry and Behavior, 98:35-42; 2011.
Research interests
- Medications development and evaluation for the treatment of chronic pain and drug abuse
- Opioid receptor interactions
- Gut microbiome regulation of inflammation and pain